Skip to main content


Full Schedule

Full Schedule

  • Sunday, October 17, 2021
  • 8:30 AM – 9:45 AM EDT
    Independent Satellite Symposium: Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies
  • 10:00 AM – 11:00 AM EDT
    Oncology Urgent Care Clinics: Understanding Utilization and Best Practices
  • 10:00 AM – 7:45 PM EDT
    Industry Encore Posters
  • 11:15 AM – 12:00 PM EDT
    Educate Your Patients on IMBRUVICA® (ibrutinib) Treatment - Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.
  • 12:15 PM – 1:15 PM EDT
    Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?
  • 1:30 PM – 2:15 PM EDT
    The Critical Role of Nutrition and Exercise Optimization in the Patient With Cancer
  • 2:30 PM – 3:15 PM EDT
    Raising Awareness: What the Patient Care Team Should Know About Metastatic Non-Small Cell Lung Cancer (mNSCLC) With EGFR Exon 20 Insertion Mutations - Janssen
  • 3:30 PM – 4:15 PM EDT
    Multidisciplinary Tumor Boards and Guiding Patient Care: The AP Role
  • 4:30 PM – 5:15 PM EDT
    Monjuvi (Tafasitamab-Cxix) For Use As Second-Line Therapy In Adult Patients With R/R DLBCL, In Combination With Lenalidomide - Incyte Corporation and MorphoSys US Inc.
  • 5:30 PM – 6:30 PM EDT
    Oncology Urgent Care Clinics: Understanding Utilization and Best Practices
  • 6:45 PM – 7:45 PM EDT
    Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?
  • 8:00 PM – 9:15 PM EDT
    Independent Satellite Symposium: Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies